Related Experiment Video
Updated: Nov 18, 2025

Author Spotlight: Decoding Corneal Neovascularization with Alkali Burn Model for Future Therapeutic Strategies
Published on: June 30, 2023
Inhibition of PDGF-BB reduces alkali-induced corneal neovascularization in mice
Lei Chen1, Hongya Wu2, Chi Ren1
1Department of Ophthalmology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, P.R. China.
Abstract:
The aim of the present study was to investigate the role of platelet‑derived growth factor (PDGF)‑BB/PDGF receptor (R)‑β signaling in an experimental murine corneal neovascularization (CrNV) model. Experimental CrNV was induced by alkali injury. The intra‑corneal expression of PDGF‑BB was examined using immunohistochemistry. The effect of PDGF‑BB on CrNV was evaluated using immunofluorescence staining. The expression levels of PDGFR‑β in human retinal endothelial cells (HRECs) under normal conditions or following cobalt chloride treatment, which induced hypoxic conditions, was assessed using reverse transcription‑quantitative PCR. The effect of exogenous treatment of PDGF‑BB on the proliferation, migration and tube formation of HRECs under normoxic or hypoxic conditions was evaluated in vitro using Cell Counting Kit‑8, wound healing and 3D Matrigel capillary tube formation assays, respectively. The results indicated that the intra‑corneal expression levels of the proteins of PDGF‑BB and PDGFR‑β were detectable on days 2 and 7 following alkali injury. The treatment with neutralizing anti‑PDGF‑BB antibody resulted in significant inhibition of CrNV. The intra‑corneal expression levels of vascular endothelial growth factor A, matrix metallopeptidase (MMP)‑2 and MMP‑9 proteins were downregulated, while the expression levels of thrombospondin (TSP)‑1, TSP‑2, a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS)‑1 and ADAMTS‑2 were upregulated significantly in mice treated with anti‑PDGF‑BB antibody. The expression levels of PDGFR‑β were upregulated in HRECs under hypoxic conditions compared with those noted under normoxic conditions. Recombinant human PDGF‑BB promoted the proliferation, migration and tube formation of HRECs under hypoxic conditions. The data indicated that PDGF‑BB/PDGFR‑β signaling was involved in CrNV and that it promoted endothelial cell proliferation, migration and tube formation. The pro‑angiogenic effects of this pathway may be mediated via the induction of pro‑angiogenic cytokine secretion and the suppression of anti‑angiogenic cytokine secretion.
Insights
Platelet-derived growth factor (PDGF)-BB/PDGF receptor (R)-β signaling promotes corneal neovascularization by enhancing endothelial cell activity. Inhibiting this pathway reduces new blood vessel growth in the cornea.
Area of Science:
- Ophthalmology
- Molecular Biology
- Cell Biology
Background:
- Corneal neovascularization (CrNV) is a significant cause of vision impairment.
- The molecular mechanisms driving CrNV, particularly the role of growth factors, require further elucidation.
Purpose of the Study:
- To investigate the role of platelet-derived growth factor (PDGF)-BB/PDGF receptor (R)-β signaling in an experimental murine corneal neovascularization (CrNV) model.
- To determine the effects of PDGF-BB on endothelial cell functions in vitro.
Main Methods:
- Corneal neovascularization was induced by alkali injury in mice.
- Immunohistochemistry and immunofluorescence staining were used to assess protein expression.
- Reverse transcription-quantitative PCR (RT-qPCR) evaluated gene expression in human retinal endothelial cells (HRECs).
- In vitro assays (Cell Counting Kit-8, wound healing, 3D Matrigel assay) assessed HREC proliferation, migration, and tube formation.
Main Results:
- PDGF-BB and PDGFR-β expression increased in the cornea post-injury.
- Neutralizing anti-PDGF-BB antibody significantly inhibited CrNV.
- PDGF-BB/PDGFR-β signaling promoted HREC proliferation, migration, and tube formation, especially under hypoxic conditions.
- Inhibition of PDGF-BB signaling altered the expression of pro- and anti-angiogenic factors.
Conclusions:
- PDGF-BB/PDGFR-β signaling plays a crucial role in promoting corneal neovascularization.
- This pathway enhances endothelial cell proliferation, migration, and tube formation.
- Targeting PDGF-BB/PDGFR-β signaling may offer a therapeutic strategy for managing CrNV.

